Shu-Min Wang Selected Research

Neuroprotective Agents

1/2021

Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shu-Min Wang Research Topics

Disease

8	Neoplasms (Cancer) 04/2024 - 05/2012
2	Neoplasm Metastasis (Metastasis) 10/2022 - 08/2019
2	Liver Neoplasms (Liver Cancer) 03/2022 - 05/2012
2	Carcinogenesis 03/2022 - 05/2012
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2019
2	Thrombosis (Thrombus) 05/2020 - 08/2019
2	Inflammation (Inflammations) 01/2020 - 10/2017
1	Hyperuricemia 01/2023
1	Acute Lung Injury 12/2022
1	Rectal Neoplasms (Rectal Cancer) 10/2022
1	False Aneurysm (Pseudoaneurysm) 10/2021
1	Primary Hyperparathyroidism 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hemorrhage 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Insulin Resistance 01/2019
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2017
1	Retinal Degeneration 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017
1	Gliosis 10/2017
1	Carcinoma (Carcinomatosis) 10/2013
1	Iron Deficiencies 01/2008
1	Anemia 01/2008
1	Chronic Renal Insufficiency 01/2008
1	Chronic Hepatitis B 02/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2003
1	Hepatitis 02/2003

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2003
3	OsteocalcinIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2022
2	Therapeutic UsesIBA 10/2022 - 01/2020
2	heparanaseIBA 03/2022 - 05/2012
1	EnzymesIBA 04/2024
1	A-Form DNA (A-DNA)IBA 04/2024
1	EndonucleasesIBA 04/2024
1	Messenger RNA (mRNA)IBA 12/2023
1	Catalytic DNA (Deoxyribozyme)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	purineIBA 01/2023
1	potassium oxonateIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	HypoxanthineIBA 01/2023
1	Organic Anion Transport Protein 1IBA 01/2023
1	pterostilbeneIBA 12/2022
1	PolyphenolsIBA 12/2022
1	vasectrin II (VS II)IBA 10/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2022
1	AntigensIBA 10/2022
1	Neuroprotective AgentsIBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	PropionatesIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Flufenamic AcidIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Hemoglobins (Hemoglobin)IBA 08/2019
1	Alkaline PhosphataseIBA 08/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 10/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2017
1	MelatoninIBA 10/2017
1	Chemokine CXCL10IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017
1	Capsules (Microcapsules)IBA 01/2014
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2013
1	Small Interfering RNA (siRNA)IBA 05/2012
1	Erythropoietin FDA Link 01/2008

Therapy/Procedure

1	Oral Administration 01/2023
1	Neoadjuvant Therapy 10/2022
1	Vena Cava Filters (Inferior Vena Cava Filter) 10/2021
1	Nephrectomy 05/2020
1	Operative Surgical Procedures 05/2020
1	Thrombectomy 05/2020
1	Blood Transfusion (Blood Transfusions) 08/2019
1	Operative Time 08/2019
1	Lasers (Laser) 01/2014
1	Therapeutics 01/2014
1	Precision Medicine 01/2014